Hirshfield KM - Search Results

1

Systemic therapy, survival and end-of-life costs for metastatic triple-negative breast cancer: retrospective SEER-Medicare study of women age ≥65 years.

Sieluk J, Yang L, Haiderali A, Huang M, Hirshfield KM. Sieluk J, et al. Among authors: hirshfield km. Future Oncol. 2021 Jul;17(20):2581-2592. doi: 10.2217/fon-2021-0019. Epub 2021 Mar 25. Future Oncol. 2021. PMID: 33764155

2

Robust automatic breast cancer staging using a combination of functional genomics and image-omics.

Su H, Shen Y, Xing F, Qi X, Hirshfield KM, Yang L, Foran DJ. Su H, et al. Among authors: hirshfield km. Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:7226-9. doi: 10.1109/EMBC.2015.7320059. Annu Int Conf IEEE Eng Med Biol Soc. 2015. PMID: 26737959 Free PMC article.

3

Early triple-negative breast cancer in women aged ≥65: retrospective study of outcomes, resource use and costs, 2010-2016.

Sieluk J, Haiderali A, Huang M, Yang L, Hirshfield KM. Sieluk J, et al. Among authors: hirshfield km. Future Oncol. 2021 Mar;17(9):1039-1054. doi: 10.2217/fon-2020-0996. Epub 2020 Dec 2. Future Oncol. 2021. PMID: 33261515

4

The Economic Burden of Recurrence in Triple-Negative Breast Cancer Among Working Age Patients in the United States.

Sieluk J, Song Y, Freimark J, Huang M, Haiderali A, Berman R, Wang T, Signorovitch J, Hirshfield KM. Sieluk J, et al. Among authors: hirshfield km. Adv Ther. 2022 Feb;39(2):943-958. doi: 10.1007/s12325-021-01913-5. Epub 2021 Dec 17. Adv Ther. 2022. PMID: 34918193

5

Real-world perioperative treatment patterns and economic burden of recurrence in early-stage HER2-negative breast cancer: a SEER-Medicare study.

Earla JR, Kponee-Shovein K, Kurian AW, Mahendran M, Song Y, Hua Q, Hilts A, Sun Y, Hirshfield KM, Mejia JA. Earla JR, et al. Among authors: hirshfield km. J Med Econ. 2025 Dec;28(1):54-69. doi: 10.1080/13696998.2024.2439228. Epub 2024 Dec 19. J Med Econ. 2025. PMID: 39648858 Free article.

6

Triple-negative breast cancer: molecular subtypes and targeted therapy.

Hirshfield KM, Ganesan S. Hirshfield KM, et al. Curr Opin Obstet Gynecol. 2014 Feb;26(1):34-40. doi: 10.1097/GCO.0000000000000038. Curr Opin Obstet Gynecol. 2014. PMID: 24346128 Review.

7

Effects of breast cancer on chronic disease medication adherence among older women.

Santorelli ML, Steinberg MB, Hirshfield KM, Rhoads GG, Bandera EV, Lin Y, Demissie K. Santorelli ML, et al. Among authors: hirshfield km. Pharmacoepidemiol Drug Saf. 2016 Aug;25(8):898-907. doi: 10.1002/pds.3971. Epub 2016 Feb 15. Pharmacoepidemiol Drug Saf. 2016. PMID: 26875432

8

Hormonal therapy for breast cancer and diabetes incidence among postmenopausal women.

Santorelli ML, Hirshfield KM, Steinberg MB, Rhoads GG, Lin Y, Demissie K. Santorelli ML, et al. Among authors: hirshfield km. Ann Epidemiol. 2016 Jun;26(6):436-40. doi: 10.1016/j.annepidem.2016.04.004. Epub 2016 Apr 12. Ann Epidemiol. 2016. PMID: 27157863

9

Racial differences in the effects of comorbidity on breast cancer-specific survival.

Santorelli ML, Hirshfield KM, Steinberg MB, Lin Y, Rhoads GG, Bandera EV, Demissie K. Santorelli ML, et al. Among authors: hirshfield km. Cancer Causes Control. 2017 Aug;28(8):809-817. doi: 10.1007/s10552-017-0915-x. Epub 2017 Jun 22. Cancer Causes Control. 2017. PMID: 28643109

10

Diagnosis and treatment delays among elderly breast cancer patients with pre-existing mental illness.

Iglay K, Santorelli ML, Hirshfield KM, Williams JM, Rhoads GG, Lin Y, Demissie K. Iglay K, et al. Among authors: hirshfield km. Breast Cancer Res Treat. 2017 Nov;166(1):267-275. doi: 10.1007/s10549-017-4399-x. Epub 2017 Jul 19. Breast Cancer Res Treat. 2017. PMID: 28726159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters